Cargando…

Xeno-Free Human Wharton’s Jelly Mesenchymal Stromal Cells Maintain Their Characteristic Properties after Long-Term Cryopreservation

OBJECTIVE: The past decade has witnessed a rapid growth in harnessing the potential of adult stem cells for regenerative medicine. An investigational new drug (IND) or a regenerative medicine advanced therapy (RMAT) product must fulfil many requirements, such as stability studies, after cryopreserva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathen, Caroline, Dsouza, Wilfrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royan Institute 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181313/ https://www.ncbi.nlm.nih.gov/pubmed/34096215 http://dx.doi.org/10.22074/cellj.2021.7131

Ejemplares similares

A Three-Dimensional Xeno-Free Culture Condition for Wharton’s Jelly-Mesenchymal Stem Cells: The Pros and Cons
por: Koh, Benson, et al.
Publicado: (2023)

Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions
por: Venugopal, Parvathy, et al.
Publicado: (2011)

Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells
por: Badraiq, Heba, et al.
Publicado: (2017)

The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019)

Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton’s jelly-derived mesenchymal stem cells
por: Corotchi, Maria Cristina, et al.
Publicado: (2013)

Comparative study of the methods of extracting mesenchymal stem cells from cryopreserved Wharton’s Jelly
por: Boey, Peng Yew Kenny, et al.
Publicado: (2017)

Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Are the Immune Properties of Mesenchymal Stem Cells from Wharton’s Jelly Maintained during Chondrogenic Differentiation?
por: Voisin, Charlotte, et al.
Publicado: (2020)

DMSO‐ and Serum‐Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord
por: Shivakumar, Sharath Belame, et al.
Publicado: (2016)

Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study
por: Swamynathan, Priyanka, et al.
Publicado: (2014)

Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
por: Davies, John E., et al.
Publicado: (2017)

A Xeno-Free Strategy for Derivation of Human Umbilical Vein Endothelial Cells and Wharton's Jelly Derived Mesenchymal Stromal Cells: A Feasibility Study toward Personal Cell and Vascular Based Therapy
por: Kunkanjanawan, Hataiwan, et al.
Publicado: (2020)

The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021)

Xeno-Free Condition Enhances Therapeutic Functions of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells against Experimental Colitis by Upregulated Indoleamine 2,3-Dioxygenase Activity
por: Kang, Ji Yeon, et al.
Publicado: (2020)

Shipping Temperature, Time and Media Effects on Equine Wharton’s Jelly and Adipose Tissue Derived Mesenchymal Stromal Cells Characteristics
por: Iacono, Eleonora, et al.
Publicado: (2022)

Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton’s Jelly
por: Sypecka, Monika, et al.
Publicado: (2022)

Isolation and characterization of Wharton’s jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system
por: Cardoso, Tereza C, et al.
Publicado: (2012)

Osteogenic commitment of Wharton’s jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application
por: Cabrera-Pérez, Raquel, et al.
Publicado: (2019)

AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)

Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton’s jelly mesenchymal stromal cells
por: Rengasamy, Mathiyazhagan, et al.
Publicado: (2017)

Evaluation of HLA-G Expression in Multipotent Mesenchymal Stromal Cells Derived from Vitrified Wharton’s Jelly Tissue
por: Mallis, Panagiotis, et al.
Publicado: (2018)

Neuroprotective Action of Human Wharton’s Jelly-Derived Mesenchymal Stromal Cell Transplants in a Rodent Model of Stroke
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Efficient Non-Viral Gene Modification of Mesenchymal Stromal Cells from Umbilical Cord Wharton’s Jelly with Polyethylenimine
por: Ramos-Murillo, Ana Isabel, et al.
Publicado: (2020)

Biofabrication of a Tubular Model of Human Urothelial Mucosa Using Human Wharton Jelly Mesenchymal Stromal Cells
por: Garzón, Ingrid, et al.
Publicado: (2021)

Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells
por: Hu, Ying, et al.
Publicado: (2013)

Effects of Wharton’s jelly-derived mesenchymal stem cells on neonatal neutrophils
por: Khan, Imteyaz, et al.
Publicado: (2014)

Differentiation of Wharton's jelly mesenchymal stem cells into neurons in alginate scaffold
por: Hosseini, Seyed Mojtaba, et al.
Publicado: (2015)

Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion
por: Witkowska-Zimny, Malgorzata, et al.
Publicado: (2011)

Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021)

Antibacterial and Immunomodulatory Properties of Acellular Wharton’s Jelly Matrix
por: Dubus, Marie, et al.
Publicado: (2022)

Increased Proliferation and Analysis of Differential Gene Expression in Human Wharton's Jelly-derived Mesenchymal Stromal Cells under Hypoxia
por: Nekanti, Usha, et al.
Publicado: (2010)

Identifying Biomarkers of Wharton’s Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect
por: Laflaquière, Benoît, et al.
Publicado: (2018)

The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury
por: Chudickova, Milada, et al.
Publicado: (2019)

Wharton’s Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View
por: Muñoz-Domínguez, Noelia, et al.
Publicado: (2021)

An optimized procedure for preparation of conditioned medium from Wharton’s jelly mesenchymal stromal cells isolated from umbilical cord
por: Acuto, Santina, et al.
Publicado: (2023)

Comparison of biological characteristics of mesenchymal stem cells derived from maternal-origin placenta and Wharton’s jelly
por: Chen, Gecai, et al.
Publicado: (2015)

Hypoxia with Wharton’s jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34(+) cells
por: Zhao, Dewan, et al.
Publicado: (2018)

Wharton’s jelly‐derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation
por: Pochon, Cécile, et al.
Publicado: (2022)

Wharton’s jelly mesenchymal stem cells promote wound healing and tissue regeneration
por: Kamolz, Lars-Peter, et al.
Publicado: (2014)

Wharton's Jelly human Mesenchymal Stem Cell contact guidance by noisy nanotopographies
por: Jacchetti, E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uhsgts7sctqb1118s5jgsevo9n